Likewise, in GSE253742, MET, ETS-1, and USP9X expression levels in lung cancer tissues after osimertinib treatment were elevated compared to untreated lung cancer tissues, supporting our research findings (Supplementary Fig. 4C). Here, USP9X is linked to lung cancer.